[ad_1] -Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, double-blind, placebo-controlled, multicenter Phase III clinical trial. HONG KONG, […]
Tag: Pharmaceuticals
D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs
[ad_1] SHANGHAI, Dec. 9, 2025 /PRNewswire/ — D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round. […]
Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
[ad_1] SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, […]
Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034)
[ad_1] The amyotrophic lateral sclerosis market is expected to grow owing to the increasing prevalence of the disease, along with the promising emerging pipeline therapies, such as Masitinib (AB Sciences), PrimeC (Neurosense Therapeutics), RNS60 (Revalesio), […]
SHAKLEE ANNOUNCES RECORD GROWTH AS INNOVATION AND COMMUNITY MOMENTUM FUEL A NEW ERA OF LONGEVITY WELLNESS
[ad_1] MIAMI, Dec. 9, 2025 /PRNewswire/ — Shaklee, the original wellness company and a leader in longevity science, today announced record-breaking growth, marking one of the strongest periods in its 70-year history. The company reported […]
